Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD

Abroad (travel likely)RecruitingPHASE1

Conditions

Graft vs Host Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Contact: Study coordinator (Ting YANG, Prof.) · yang.hopeting@gmail.com · 86-591-88711593
Contact: Principal Investigator (Ting YANG, Prof.)

Study leads

Ting YANG, Prof.
Principal Investigator
First Affiliated Hospital of Fujian Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD

Graft vs Host Disease

Abroad (travel likely)Recruiting

Hangzhou, China

Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD

Graft vs Host Disease

Abroad (travel likely)RecruitingPHASE2

Taoyuan, Taiwan

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation

Graft Vs Host Disease · Vulvovaginal Signs and Symptoms

Abroad (travel likely)Recruiting

Cleveland, United States

Fatigue and Cognitive Dysfunction Due to Synaptopathy or Graft Versus Host (GVH) Disease in the Brain.

Fatigue · Graft Vs Host Disease · Cognitive Dysfunction

Abroad (travel likely)Recruiting

Stockholm, Sweden